Ultimovacs ASA (OSL:ULTI) Accumulated Depreciation : kr0.00 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Ultimovacs ASA Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ultimovacs ASA's quarterly accumulated depreciation increased from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr-2.26 Mil) but then stayed the same from Dec. 2023 (kr-2.26 Mil) to Mar. 2024 (kr0.00 Mil).

Ultimovacs ASA's annual accumulated depreciation increased from Dec. 2021 (kr-1.94 Mil) to Dec. 2022 (kr-2.12 Mil) and increased from Dec. 2022 (kr-2.12 Mil) to Dec. 2023 (kr-2.26 Mil).

Ultimovacs ASA Accumulated Depreciation Historical Data

The historical data trend for Ultimovacs ASA's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ultimovacs ASA Accumulated Depreciation Chart

Ultimovacs ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated Depreciation

Get a 7-Day Free Trial

-1.25

-1.69

-1.94

-2.12

-2.26

Ultimovacs ASA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-	-	-2.26	-

Ultimovacs ASA Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Ultimovacs ASA Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Ultimovacs ASA's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ultimovacs ASA (OSL:ULTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ultimovacs ASA (OSL:ULTI) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

ULTIo:Sweden 7UM:Germany

Address

Ullernchausseen 64, Oslo, NOR, 0379

Website

https://www.ultimovacs.com

Ultimovacs ASA is a pharmaceutical company involved in developing novel immunotherapies against cancer. Its product candidate is UV1, a peptide-based vaccine inducing T cell responses against the universal cancer antigen telomerase. The company and its proprietary technology are based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital.